Market Capitalization (Millions $) |
0 |
Shares
Outstanding (Millions) |
40 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-9 |
Cash Flow (TTM) (Millions $) |
-1 |
Capital Exp. (TTM) (Millions $) |
0 |
Scopus Biopharma Inc
Scopus Biopharma Inc is a pharmaceutical company that specializes in developing and commercializing innovative therapies for various diseases. The company focuses on the research and development of biopharmaceutical products, with an emphasis on drugs that target autoimmune diseases and cancer. Their aim is to address unmet medical needs and provide patients with more effective treatment options. Scopus Biopharma Inc leverages advanced technologies and scientific expertise to deliver novel therapies to the market and improve patient outcomes.
Company Address: 420 Lexington Avenue, Suite 300 New York 10170 NY
Company Phone Number: 479-2513 Stock Exchange / Ticker: SCPS
SCPS is expected to report next financial results on April 13, 2024. |
|
|